ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic …

JE Castro, CE Prada, O Loria, A Kamal, L Chen… - Blood, 2005 - ashpublications.org
JE Castro, CE Prada, O Loria, A Kamal, L Chen, FJ Burrows, TJ Kipps
Blood, 2005ashpublications.org
The zeta-associated protein of 70 kDa (ZAP-70) is expressed in patients with aggressive
chronic lymphocytic leukemia (CLL). We found that ZAP-70+ CLL cells expressed activated
heat-shock protein 90 (Hsp90) with high binding affinity for Hsp90 inhibitors, such as 17-allyl-
amino-demethoxy-geldanamycin (17-AAG), whereas normal lymphocytes or ZAP-70-CLL
cells expressed nonactivated Hsp90. Activated Hsp90 bound and stabilized ZAP-70, which
behaved like an Hsp90 client protein only in CLL cells. Treatment with Hsp90 inhibitors such …
Abstract
The zeta-associated protein of 70 kDa (ZAP-70) is expressed in patients with aggressive chronic lymphocytic leukemia (CLL). We found that ZAP-70+ CLL cells expressed activated heat-shock protein 90 (Hsp90) with high binding affinity for Hsp90 inhibitors, such as 17-allyl-amino-demethoxy-geldanamycin (17-AAG), whereas normal lymphocytes or ZAP-70- CLL cells expressed nonactivated Hsp90. Activated Hsp90 bound and stabilized ZAP-70, which behaved like an Hsp90 client protein only in CLL cells. Treatment with Hsp90 inhibitors such as 17-AAG and 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) induced ZAP-70 degradation and apoptosis in CLL cells but not in T cells, and also impaired B-cell receptor signaling in leukemia cells. Transduction of ZAP-70- CLL cells with an adenovirus encoding ZAP-70 activated Hsp90 and specifically rendered the leukemia cells sensitive to 17-AAG. These data indicate that Hsp90 is necessary for ZAP-70 expression and activity; that ZAP-70 is unique among Hsp90 clients, in that its chaperone-dependency is conditional on the cell type in which it is expressed; and also that ZAP-70 is required for cell survival and signaling in CLL. Additionally, ZAP-70 expression in CLL cells confers markedly heightened sensitivity to 17-AAG or 17-DMAG, suggesting that these or other Hsp90 inhibitors could be valuable therapeutically in patients with aggressive CLL. (Blood. 2005;106:2506-2512)
ashpublications.org